Exact Sciences Total Assets 2006-2020 | EXAS

Exact Sciences total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Exact Sciences total assets for the quarter ending March 31, 2020 were $4.461B, a 151.96% increase year-over-year.
  • Exact Sciences total assets for 2019 were $3.506B, a 130.03% increase from 2018.
  • Exact Sciences total assets for 2018 were $1.524B, a 154.61% increase from 2017.
  • Exact Sciences total assets for 2017 were $0.599B, a 58.75% increase from 2016.
Exact Sciences Annual Total Assets
(Millions of US $)
2019 $3,506
2018 $1,524
2017 $599
2016 $377
2015 $364
2014 $313
2013 $147
2012 $112
2011 $97
2010 $97
2009 $26
2008 $6
2007 $15
2006 $24
2005 $38
Exact Sciences Quarterly Total Assets
(Millions of US $)
2020-03-31 $4,461
2019-12-31 $3,506
2019-09-30 $1,759
2019-06-30 $1,782
2019-03-31 $1,771
2018-12-31 $1,524
2018-09-30 $1,510
2018-06-30 $1,483
2018-03-31 $1,257
2017-12-31 $599
2017-09-30 $587
2017-06-30 $583
2017-03-31 $350
2016-12-31 $377
2016-09-30 $403
2016-06-30 $289
2016-03-31 $324
2015-12-31 $364
2015-09-30 $394
2015-06-30 $253
2015-03-31 $279
2014-12-31 $313
2014-09-30 $235
2014-06-30 $256
2014-03-31 $134
2013-12-31 $147
2013-09-30 $155
2013-06-30 $163
2013-03-31 $100
2012-12-31 $112
2012-09-30 $123
2012-06-30 $76
2012-03-31 $88
2011-12-31 $97
2011-09-30 $78
2011-06-30 $85
2011-03-31 $91
2010-12-31 $97
2010-09-30 $36
2010-06-30 $39
2010-03-31 $24
2009-12-31 $26
2009-09-30 $28
2009-06-30 $29
2009-03-31 $22
2008-12-31 $6
2008-09-30 $7
2008-06-30 $10
2008-03-31 $12
2007-12-31 $15
2007-09-30 $17
2007-06-30 $19
2007-03-31 $21
2006-12-31 $24
2006-09-30 $27
2006-06-30 $30
2006-03-31 $33
2005-12-31 $38
2005-09-30 $41
2005-06-30 $46
2005-03-31 $50
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.296B $0.876B
EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $132.244B 14.56
Gilead Sciences (GILD) United States $93.953B 12.18
CSL (CSLLY) Australia $87.268B 0.00
Vertex Pharmaceuticals (VRTX) United States $72.211B 49.65
Regeneron Pharmaceuticals (REGN) United States $59.851B 23.07
Illumina (ILMN) United States $53.482B 54.96
Biogen (BIIB) United States $49.195B 8.42
Seattle Genetics (SGEN) United States $26.479B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.439B 10.07
Incyte (INCY) United States $21.350B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.386B 0.00
Genmab (GMAB) Denmark $19.382B 15.96
Moderna (MRNA) United States $19.370B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.295B 174.92
Genmab (GNMSF) Denmark $18.186B 53.99
Alnylam Pharmaceuticals (ALNY) United States $15.311B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $12.821B 37.96
BeiGene (BGNE) Cayman Islands $12.445B 0.00
Sarepta Therapeutics (SRPT) United States $12.257B 0.00
BioNTech SE (BNTX) Germany $10.768B 0.00
Bio-Techne Corp (TECH) United States $9.834B 64.97
QIAGEN (QGEN) Netherlands $9.798B 28.49
Horizon Therapeutics Public (HZNP) Ireland $9.367B 23.05
ARGENX SE-ADR (ARGX) Netherlands $9.141B 0.00
Guardant Health (GH) United States $8.297B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.891B 0.00
Immunomedics (IMMU) United States $7.890B 0.00
Exelixis (EXEL) United States $7.482B 26.24
Ascendis Pharma (ASND) Denmark $7.047B 0.00
Repligen (RGEN) United States $6.699B 117.50
Acceleron Pharma (XLRN) United States $5.356B 0.00
Reata Pharmaceuticals (RETA) United States $5.078B 0.00
MyoKardia (MYOK) United States $4.994B 0.00
Adaptive Biotechnologies (ADPT) United States $4.959B 0.00
Mirati Therapeutics (MRTX) United States $4.540B 0.00
Emergent Biosolutions (EBS) United States $4.411B 28.91
Global Blood Therapeutics (GBT) United States $4.303B 0.00
China Biologic Products (CBPO) China $4.256B 23.66
Ultragenyx Pharmaceutical (RARE) United States $4.242B 0.00
MorphoSys AG (MOR) Germany $4.234B 32.84
Zai Lab (ZLAB) China $3.919B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.901B 85.24
Momenta Pharmaceuticals (MNTA) United States $3.836B 0.00
Vir Biotechnology (VIR) United States $3.796B 0.00
Blueprint Medicines (BPMC) United States $3.485B 0.00
Bluebird Bio (BLUE) United States $3.432B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.276B 0.00
Halozyme Therapeutics (HALO) United States $3.255B 0.00
Amicus Therapeutics (FOLD) United States $3.208B 0.00
NeoGenomics (NEO) United States $3.006B 219.54
Arena Pharmaceuticals (ARNA) United States $2.927B 0.00
UniQure (QURE) Netherlands $2.906B 0.00
Denali Therapeutics (DNLI) United States $2.892B 0.00
Amarin (AMRN) Ireland $2.683B 0.00
Alkermes (ALKS) Ireland $2.658B 52.33
Novavax (NVAX) United States $2.635B 0.00
Viela Bio (VIE) United States $2.630B 0.00
Alector (ALEC) United States $2.588B 0.00
Insmed (INSM) United States $2.582B 0.00
Fate Therapeutics (FATE) United States $2.571B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.452B 0.00
Principia Biopharma (PRNB) United States $2.243B 0.00
Inovio Pharmaceuticals (INO) United States $2.085B 0.00
Epizyme (EPZM) United States $1.904B 0.00
Eidos Therapeutics (EIDX) United States $1.869B 0.00
Zymeworks (ZYME) Canada $1.777B 0.00
Ligand Pharmaceuticals (LGND) United States $1.682B 65.48
Adverum Biotechnologies (ADVM) United States $1.681B 0.00
Arvinas (ARVN) United States $1.679B 0.00
Sangamo Therapeutics (SGMO) United States $1.611B 0.00
REGENXBIO (RGNX) United States $1.581B 0.00
Twist Bioscience (TWST) United States $1.554B 0.00
Mesoblast (MESO) Australia $1.533B 0.00
Editas Medicine (EDIT) United States $1.532B 0.00
Akcea Therapeutics (AKCA) United States $1.524B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.507B 0.00
Intra-Cellular Therapies (ITCI) United States $1.463B 0.00
I-Mab (IMAB) China $1.384B 0.00
NGM Biopharmaceuticals (NGM) United States $1.383B 0.00
Zealand Pharma (ZEAL) Denmark $1.372B 0.00
PHARMA MAR SA (PHMMF) Spain $1.363B 0.00
Coherus BioSciences (CHRS) United States $1.358B 9.48
Beam Therapeutics (BEAM) United States $1.266B 0.00
Cytokineticsorporated (CYTK) United States $1.263B 0.00
Revance Therapeutics (RVNC) United States $1.258B 0.00
Arcus Biosciences (RCUS) United States $1.246B 0.00
Myriad Genetics (MYGN) United States $1.088B 56.12
Sorrento Therapeutics (SRNE) United States $1.084B 0.00
Mersana Therapeutics (MRSN) United States $1.072B 0.00
NextCure (NXTC) United States $0.950B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.942B 0.00
Athenex (ATNX) United States $0.936B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.933B 0.00
Intellia Therapeutics (NTLA) United States $0.917B 0.00
Compugen (CGEN) Israel $0.903B 0.00
Pharming Group (PHGUF) Netherlands $0.901B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Heska (HSKA) United States $0.817B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.802B 0.00
Cellectis S.A (CLLS) France $0.801B 0.00
Cue Biopharma (CUE) United States $0.772B 0.00
Alcobra (ARCT) United States $0.767B 0.00
Cara Therapeutics (CARA) United States $0.752B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.748B 0.00
NantKwest (NK) United States $0.747B 0.00
Kadmon Holdings (KDMN) United States $0.733B 0.00
Codexis (CDXS) United States $0.726B 0.00
Morphic Holding (MORF) United States $0.697B 0.00
Retrophin (RTRX) United States $0.697B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.686B 0.00
Kala Pharmaceuticals (KALA) United States $0.672B 0.00
Castle Biosciences (CSTL) United States $0.659B 0.00
Vericel (VCEL) United States $0.646B 119.25
Sinovac Biotech (SVA) China $0.640B 17.03
Bellus Health (BLU) Canada $0.631B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.622B 0.00
Stemline Therapeutics (STML) United States $0.618B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.608B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.607B 5.20
MeiraGTx Holdings (MGTX) United States $0.597B 0.00
Scholar Rock Holding (SRRK) United States $0.576B 0.00
Frequency Therapeutics (FREQ) United States $0.562B 0.00
Athersys (ATHX) United States $0.560B 0.00
AnaptysBio (ANAB) United States $0.543B 0.00
UROGEN PHARMA (URGN) United States $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Clovis Oncology (CLVS) United States $0.529B 0.00
DBV Technologies S.A (DBVT) France $0.523B 0.00
AC Immune SA (ACIU) Switzerland $0.521B 0.00
VBI Vaccines (VBIV) United States $0.501B 0.00
Anika Therapeutics (ANIK) United States $0.497B 15.97
Autolus Therapeutics (AUTL) United Kingdom $0.486B 0.00
BioDelivery Sciences (BDSI) United States $0.480B 25.26
Xenon Pharmaceuticals (XENE) Canada $0.468B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.466B 0.00
Protagonist Therapeutics (PTGX) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.461B 0.00
Agenus (AGEN) United States $0.460B 0.00
Cel-Sci (CVM) United States $0.459B 0.00
Dynavax Technologies (DVAX) United States $0.455B 0.00
Syros Pharmaceuticals (SYRS) United States $0.446B 0.00
Intrexon (PGEN) United States $0.429B 0.00
Puma Biotechnology (PBYI) United States $0.425B 0.00
Seres Therapeutics (MCRB) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.415B 0.00
Merus (MRUS) Netherlands $0.414B 0.00
Albireo Pharma (ALBO) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.403B 0.00
MiMedx (MDXG) United States $0.401B 0.00
PDL BioPharma (PDLI) United States $0.387B 332.00
ANI Pharmaceuticals (ANIP) United States $0.383B 7.58
Precision BioSciences (DTIL) United States $0.364B 0.00
WAVE Life Sciences (WVE) Singapore $0.363B 0.00
Kamada (KMDA) Israel $0.350B 14.56
Selecta Biosciences (SELB) United States $0.338B 0.00
Menlo Therapeutics (MNLO) United States $0.331B 0.00
Geron (GERN) United States $0.329B 0.00
MannKind (MNKD) United States $0.324B 0.00
OSMOTICA PHARM (OSMT) United States $0.309B 0.00
Avid Bioservices (CDMO) United States $0.308B 0.00
ChromaDex (CDXC) United States $0.294B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.292B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.285B 0.00
Verastem (VSTM) United States $0.284B 0.00
Starpharma Holdings (SPHRY) Australia $0.281B 0.00
Abeona Therapeutics (ABEO) United States $0.276B 0.00
Cellular Biomedicine (CBMG) United States $0.266B 0.00
Aduro Biotech (ADRO) United States $0.265B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
Liquidia Technologies (LQDA) United States $0.257B 0.00
Fortress Biotech (FBIO) United States $0.247B 0.00
HOOKIPA Pharma (HOOK) United States $0.246B 0.00
Spero Therapeutics (SPRO) United States $0.245B 0.00
Gritstone Oncology (GRTS) United States $0.244B 0.00
Prometic Life Sciences (LMNL) Canada $0.241B 0.00
Affimed (AFMD) Germany $0.241B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.239B 0.00
Pfenex (PFNX) United States $0.238B 0.00
Northwest Biotherapeutics (NWBO) United States $0.238B 0.00
XOMA (XOMA) United States $0.226B 0.00
Sutro Biopharma (STRO) United States $0.225B 0.00
Exicure (XCUR) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.217B 3.27
IVERIC Bio (ISEE) United States $0.210B 0.00
GENFIT S.A (GNFT) France $0.206B 0.00
VTv Therapeutics (VTVT) United States $0.200B 0.00
Pluristem Therapeutics (PSTI) Israel $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.197B 0.00
ARAVIVE, INC (ARAV) United States $0.195B 0.00
IBio (IBIO) United States $0.192B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.190B 0.00
Aptinyx (APTX) United States $0.180B 0.00
Kindred Biosciences (KIN) United States $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
Aytu Bioscience (AYTU) United States $0.173B 0.00
Dyadic (DYAI) United States $0.166B 0.00
TELA Bio (TELA) United States $0.164B 0.00
Cerecor (CERC) United States $0.163B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Antibe Therapeutics (ATBPF) Canada $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.153B 0.00
Orgenesis (ORGS) United States $0.151B 0.00
Trevena (TRVN) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Enzo Biochem (ENZ) United States $0.142B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Applied Genetic Technologies (AGTC) United States $0.130B 0.00
VolitionRX (VNRX) United States $0.129B 0.00
PHASEBIO PHARMA (PHAS) United States $0.127B 0.00
CorMedix Inc (CRMD) United States $0.127B 0.00
Palatin Technologies (PTN) United States $0.126B 3.23
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.122B 0.00
Cyclerion Therapeutics (CYCN) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.113B 0.00
Protalix BioTherapeutics (PLX) Israel $0.111B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.110B 0.00
Eton Pharmaceuticals (ETON) United States $0.101B 0.00
Oncobiologics (OTLK) United States $0.096B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
AquaBounty Technologies (AQB) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
Celsion (CLSN) United States $0.085B 0.00
Synlogic (SYBX) United States $0.080B 0.00
Organovo Holdings (ONVO) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Proteostasis Therapeutics (PTI) United States $0.077B 0.00
Stealth BioTherapeutics (MITO) United States $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
DiaMedica Therapeutics (DMAC) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Apricus Biosciences (SEEL) United States $0.053B 0.00
Cocrystal Pharma (COCP) United States $0.052B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Signal Genetics (MGEN) United States $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Advaxis (ADXS) United States $0.043B 0.00
OvaScience (MLND) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.038B 0.00
Cesca Therapeutics (THMO) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
TOCAGEN INC (TOCA) United States $0.034B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Curis (CRIS) United States $0.030B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
TrovaGene (CRDF) United States $0.028B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Spherix (AIKI) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
VIVUS (VVUS) United States $0.022B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00